Padosev IV infusion 30mg, manufactured by Astellas Pharma, contains Enfortumab vedotin (genetical recombination). This antibody-drug conjugate targets Nectin-4 on cancer cells, delivering a cytotoxic agent to induce cell cycle arrest and apoptosis. It is provided as 30mg per bottle, with YJ code 4291459D1020.
Padosev IV infusion 30mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
